Imatinib-induced postoperative periorbital purpura: GASP (Gleevec-Associated Surgical Purpura) in a woman with imatinib-treated chronic myelogenous leukemia.

Conclusion: We recommend discontinuing imatinib usage one week prior to periorbital surgery and not resuming therapy until the eighth postoperative day. PMID: 24456946 [PubMed - in process]

http://www.ncbi.nlm.nih.gov/pubmed/24456946?dopt=Abstract

Source: Dermatol Online J - February 3, 2014 Category: Dermatology Authors: Anzalone CL, Cohen PR, Kurzrock R, Cortes JE Tags: Dermatol Online J Source Type: research